Mason & Associates Inc Makes New Investment in Astera Labs, Inc. $ALAB

Mason & Associates Inc bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,340 shares of the company’s stock, valued at approximately $235,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Reflection Asset Management acquired a new stake in shares of Astera Labs during the fourth quarter worth about $25,000. Smartleaf Asset Management LLC raised its holdings in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares in the last quarter. Hilltop National Bank lifted its holdings in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares during the period. Aventura Private Wealth LLC acquired a new stake in Astera Labs in the fourth quarter valued at $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new stake in shares of Astera Labs in the fourth quarter valued at about $33,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Morgan Stanley lifted their price objective on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Susquehanna boosted their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. TD Cowen increased their target price on Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research report on Wednesday, May 6th. Evercore reaffirmed an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a research note on Tuesday, May 19th. Finally, Citigroup downgraded Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Twelve analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $265.75.

Astera Labs Price Performance

NASDAQ:ALAB opened at $417.45 on Friday. The stock has a market cap of $71.56 billion, a P/E ratio of 282.06, a PEG ratio of 4.51 and a beta of 3.66. Astera Labs, Inc. has a 1-year low of $88.18 and a 1-year high of $499.48. The firm has a 50-day moving average of $331.43 and a two-hundred day moving average of $213.25.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same quarter last year, the firm earned $0.33 EPS. Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 8,491 shares of the stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the transaction, the director directly owned 286,863 shares in the company, valued at $131,492,261.94. This represents a 2.87% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the transaction, the director owned 57,466 shares in the company, valued at $25,859,700. This trade represents a 5.75% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 2,040,691 shares of company stock valued at $507,675,380. Corporate insiders own 10.40% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.